• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread

    Endoscopic Hemostasis Devices Market Valued at $730 Million

    Henry Schein Buys Majority Interest in Prism Medical Products

    Boston Scientific's Vercise Genus DBS Earns FDA Approval

    Biotech Team Develops ELISA Protocol for COVID-19 Antibody Detection
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    PTI Engineered Plastics Inc.

    FUTEK Advanced Sensor Technology Inc.

    Qosina Corp.

    MW Life Sciences

    Unicep
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Creganna Medical, part of TE Connectivity

    maxon

    FUTEK Advanced Sensor Technology Inc.

    Element

    MW Life Sciences
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Top30

    29. Varian Medical

    ...

    29. Varian Medical
    Related CONTENT
    • TPI Partners with Zeiss
    • Neurent Medical Closes $25 Million Series B Financing
    • FDA OKs Canon Medical's AI-Powered, 90cm Bore CT
    • Eitan Medical Receives FDA Clearance for Sapphire Infusion System
    • Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial
    07.21.20
    Rank: #29 (Last year: #28) $3.22 Billion
    Prior Fiscal: $2.91 Billion
    Percentage Change: +10.6%
    No. of Employees: 10,062
    Global Headquarters: Palo Alto, Calif.


    KEY EMPLOYEES:
    Dow R. Wilson, President and CEO
    Kolleen T. Kennedy, President, Proton Solutions, and Chief Growth Officer
    Christopher A. Toth, President, Oncology Solutions
    Gary E. Bischoping Jr., President, Interventional Oncology Solutions
    John W. Kuo, Sr. VP, General Counsel, and Corporate Secretary
    Corey Zankowski, Sr. VP, Oncology Software Solutions
    Vy H. Tran, J.D., Sr. VP, Regulatory Affairs and Quality Assurance
    Rafael Torres, Sr. VP, Strategy & Business Development
    J. Michael Bruff, Sr. VP, Finance and Chief Financial Officer
    Dr. Dee Khuntia, Sr. VP and Chief Medical Officer
    Terilyn Monroe, Chief People Officer, Sr. VP, People, Places & Communications

    The signs started off subtle—barely noticeable, really, to common folk like Frank Rosenthal: a scratchy throat, minor mouth sores, some ear discomfort.

    Minor aches and pains, Rosenthal thought to himself. Nothing to be concerned about.

    Rosenthal wasn’t concerned. Not at first, anyway.

    But his concerns grew as those aches and pains lingered, and they quickly intensified with the onset of new symptoms (“fullness” in his throat, difficulty swallowing).

    Rosenthal finally consulted a doctor after noticing a change in his singing voice.

    Turns out, the “aches and pains” that Rosenthal initially considered minor annoyances weren’t at all minor but rather the early warning signals of cancer. Base of tongue cancer, specifically.

    Rosenthal’s prognosis was good, but treating the cancer could potentially cost the avid musician his singing voice. Traditional radiation therapy would almost certainly leave Rosenthal without the ability to swallow, taste, or sing, as the high-energy waves used to destroy the cancer cells often cause the muscles and mucosal lining in the mouth, throat, and esophagus to stiffen and become deformed.

    Rosenthal couldn’t imagine living his life without song. But through research, he discovered a way to possibly save his voice: Proton therapy, an extremely precise form of cancer treatment that results in up to 60 percent less radiation and dramatically minimizes serious side effects (i.e., inability to swallow or sing).

    Traditional radiation delivers X-rays, or beams of photons, to the tumor and beyond it, which can damage nearby tissues; conversely, proton therapy delivers a beam of proton particles directly to the tumor and therefore is less likely to damage nearby tissue.

    Rosenthal was treated for his cancer on Varian Medical System’s ProBeam Proton Therapy System. He was cured of the disease and regained his taste buds in less than three months—a feat unheard of among radiation therapy-treated head and neck cancer patients.

    Post-recovery, Rosenthal and his wife went on a Mediterranean cruise, where he savored and enjoyed the regional cuisine. “My successful recovery was due to many factors,” he said. “You have to have a positive attitude and I think having a positive attitude and a fantastic support system played [a role] in my recovery.”


    ANALYST INSIGHTS: Varian is growing across market segments horizontally (Radiation Oncology and Interventional Radiology) and also making inroads geographically. Varian is poised for record growth in the coming 12 months as there will be pent-up post-COVID demand for cancer related procedures.

    —Dave Sheppard, Co-Founder and Managing Director, MedWorld Advisors



    The proton therapy system that cured Rosenthal’s cancer received a boost of support itself, as Varian introduced an improved version of its ProBeam Proton Therapy System in October 2018. The new system, ProBeam 360°, has a 30 percent smaller footprint than its predecessor and features 360-degree rotating gantry, a powerful particle accelerator, iterative cone-beam computed tomography (CBCT) imaging and high-definition pencil-beam scanning technology. The system also gives clinicians a viable path to potential next-generation treatments such as Flash therapy.

    The 360-degree rotating gantry of ProBeam 360° enables efficient intensity modulated proton therapy (IMPT), and faster treatment times by minimizing patient repositioning and re-imaging, and allowing high-quality CBCT imaging from almost any angle. RapidScan technology, available on the ProBeam 360°, simplifies the process of motion management by delivering each field in a single breath-hold. This capability increases the number of patients who can comply with breath-hold treatments like lung SBRT.

    “Proton therapy plays an important role in the fight against cancer,” Kolleen Kennedy, chief growth officer and president of Varian’s Proton Therapy Solutions, said in unveiling the new system. “We designed ProBeam 360° to efficiently deliver sophisticated treatment techniques today, and also provide customers with a pathway to potential future treatment advancements such as Flash therapy.”

    There was less foot traffic than anticipated on that pathway in FY19 (ended Sept. 27, 2019), as Varian’s Proton Solutions revenue fell 12 percent to $122.3 million. The company attributed the decrease to declining product revenues from the timing of various project completions and stages of system installations. The dropoff, however, was partially abated by an increase in service revenues.

    The Proton Solutions sales deficit, however, had a negligible impact on the company’s total sales, which rose 10.6 percent to $3.22 billion; that increase was driven largely by Varian’s Oncology Systems division, where revenue jumped 10.5 percent to $3.06 billion on higher volumes of hardware shipments and improved software sales. However, Oncology Systems sales was partially offset by a $4 million negative impact, net of the expected refund for tariff exclusions, from the U.S.-China tariff tiff.

    Higher demand for hardware products and services and increased revenue from North American software licenses bolstered Americas Oncology Systems sales. Both APAC (Asia Pacific) and EMEA (Europe, Middle East, Africa) Oncology Systems benefited from the same growth factors, but the latter region’s increase was partially neutralized by unfavorable foreign currency exchange rates. Fiscal 2019’s service revenues also included roughly $15.5 million from Cancer Treatment Services International (CTSI), a company Varian acquired last may for $283 million.

    Founded in 2006 by business executives and University of Pittsburgh Medical Center doctors, CTSI operates cancer care brand the American Oncology Institute in various South Asia locations, with a flagship hospital in Hyderabad, India. CTSI’s Oncology Solutions division is based in Pennsylvania and acts as a centralized management hub for the firm’s cancer centers. CTSI also houses a reference laboratory brand that provides University of Pittsburgh Medical Center-guided pathology services in India.

    Revenues from the Other category was $19.4 million for fiscal year 2019 and relate to acquisitions completed during FY19.

    “Our organic innovation is complemented by our disciplined acquisition strategy to expand into other addressable markets, providing the opportunity to touch more patients and accelerate growth,” Wilson said in the annual report. “Since the beginning of fiscal 2018, we have completed 10 acquisitions, including six in fiscal 2019.”

    Varian’s spending spree began in October 2018 with the purchase of cloud-based oncology-focused software developer Noona Healthcare and ramped up last spring with the acquisitions of CTSI and CyberHeart. The latter company has developed technology to use radiation therapy in the heart (cardiac radio-ablation), and other forms of cardiovascular radiosurgery. Varian’s purchase of CyberHeart could give the company a market advantage via potentially revolutionary electrophysiology ablation technology.

    Just a month after the CyberHeart purchase, Varian scooped up Alicon and Endocare for $185 million. Combined, the two firms generated $30 million in revenue in 2018.

    Based in Austin, Texas, Endocare develops hardware and software for cryoablation and microwave ablation. Its lead product—Cryocare CS, incorporates planning, placement, and treatment to simplify cryotherapy. Alicon is based in China and manufactured embolic therapy for liver cancer treatment; its signature product (Caligel) is used in more than 1,000 hospitals in the Middle Kingdom.

    After a brief mid-summer respite, Varian shelled out $90 million for Boston Scientific Corp.’s embolics microspheres business, which developed treatments for arteriovenous malformation and hypervascular tumors. The deal covered Boston Scientific’s drug-loadable Oncozene and Embozene Tandem microsphere as well as bland embolic Embozene bead products. The Oncozene and Embozene microspheres are calibrated microspheres that are engineered to provide better embolization control and improved visualization during suspension.
    Related Searches
    • tokyo institute of technology
    • carelink pro reports
    • wyss institute
    • viabahn endoprosthesis
    Suggested For You
    Medtech Matters: Medtronic Medtech Matters: Medtronic's Robotic Surgery Status
    TPI Partners with Zeiss TPI Partners with Zeiss
    Neurent Medical Closes $25 Million Series B Financing Neurent Medical Closes $25 Million Series B Financing
    FDA OKs Canon Medical FDA OKs Canon Medical's AI-Powered, 90cm Bore CT
    Eitan Medical Receives FDA Clearance for Sapphire Infusion System Eitan Medical Receives FDA Clearance for Sapphire Infusion System
    Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial
    CHF Solutions Appoints CEO CHF Solutions Appoints CEO
    Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation
    CMS Expedites Breakthrough Device Access; Industry Applauds CMS Expedites Breakthrough Device Access; Industry Applauds
    Unique Contact Lens Sensor System & Manufacturing Process Developed Unique Contact Lens Sensor System & Manufacturing Process Developed
    Medtech Matters: Talking Robotic Surgery with Zimmer Biomet Medtech Matters: Talking Robotic Surgery with Zimmer Biomet
    CES News: Philips Highlights Healthcare at Home CES News: Philips Highlights Healthcare at Home
    Olympus and Hitachi Sign Five-Year Contract Olympus and Hitachi Sign Five-Year Contract
    Acutus Medical Launches AcQCross Transseptal System in Europe Acutus Medical Launches AcQCross Transseptal System in Europe
    Study Shows Lungpacer System Improves Diaphragm Strength by More Than 300 Percent Study Shows Lungpacer System Improves Diaphragm Strength by More Than 300 Percent

    Related Top30

    • The 2020 Top 30 Global Medical Device Companies

      The 2020 Top 30 Global Medical Device Companies

      Leadership changes, divestments, and portfolio-building partnerships—through acquisition or collaboration—were common threads among medtech’s largest players.
      MPO Editors 07.21.20

    • The 2019 Top 30 Global Medical Device Companies

      The 2019 Top 30 Global Medical Device Companies

      ...
      Sean Fenske, Michael Barbella, & Sam Brusco, MPO Editorial Staff 07.30.19

    • 1. Medtronic

      1. Medtronic

      ...
      07.30.19


    • 2. Johnson & Johnson

      2. Johnson & Johnson

      ...
      07.30.19

    • 3. GE Healthcare

      3. GE Healthcare

      ...
      07.30.19

    • 4. Abbott

      4. Abbott

      ...
      07.30.19


    • 5. Philips

      5. Philips

      ...
      07.30.19

    • 6. BD

      6. BD

      ...
      07.30.19

    • 7. Cardinal Health

      7. Cardinal Health

      ...
      07.30.19


    • 7. Siemens Healthineers

      7. Siemens Healthineers

      ...
      07.30.19

    • 9. Stryker

      9. Stryker

      ...
      07.30.19

    • 10. Baxter

      10. Baxter

      ...
      07.30.19


    • 11. Boston Scientific

      11. Boston Scientific

      ...
      07.30.19

    • 12. Danaher

      12. Danaher

      ...
      07.30.19

    • 13. EssilorLuxottica

      13. EssilorLuxottica

      ...
      07.30.19


    Trending
    • Telemedicine, Regulatory Changes To Characterize Medtech Industry In 2021
    • Masimo Earns CE Mark For New Fingertip Pulse Oximeter
    • Philips Buys Capsule Technologies In $635M Deal
    • Understanding Food-Grade Vs. Biocompatibility For Medical Device Materials
    • Medtech Matters: Surgeons Scrubbing In Virtually
    Breaking News
    • Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread
    • Endoscopic Hemostasis Devices Market Valued at $730 Million
    • Henry Schein Buys Majority Interest in Prism Medical Products
    • Boston Scientific's Vercise Genus DBS Earns FDA Approval
    • Biotech Team Develops ELISA Protocol for COVID-19 Antibody Detection
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet
    Gadot Positions Mineral Line for Vegan Market
    Nutritfy India to Launch Global Broadcast Channel Covering Nutrition
    Coatings World

    Latest Breaking News From Coatings World

    PPG Reports Q4, Full-year 2020 Financial Results
    BASF Begins Implementing Ralignment of Global Business Services Unit
    Nouryon Appoints Curtis Espeland to Board of Directors
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread
    Endoscopic Hemostasis Devices Market Valued at $730 Million
    Henry Schein Buys Majority Interest in Prism Medical Products
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Top BioPharma Form Accumulus Synergy
    CONTINUUS Awarded $69.3M DoD Grant
    AbbVie Licenses ProBioGen’s GlymaxX Technology
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Coty Appoints Chief Procurement Officer
    Lageen Tubes Launches Mono-Material PE Tube Solutions
    Jason Jones Loses Battle with Covid-19
    Happi

    Latest Breaking News From Happi

    Coty Appoints Chief Procurement Officer
    Amyris To Enter Cannabinoid Beauty
    RB Buys Queen V
    Ink World

    Latest Breaking News From Ink World

    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    THIMM Group Installs 1st Koenig & Bauer CorruFLEX
    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Gallus planning virtual event for March
    Lemu Group engineers mask-making machine
    Niagara Label upgrades with Nilpeter flexo press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Freudenberg to Establish Apparel Interlining Competence Centers
    Minet Adds Spunlace Line in Romania
    Lemu Group Engineers Mask-Making Machine
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Conformis Enters Development & Supply Agreement with SITES Medical
    Sectra, RSA Biomedical Sign Distribution Agreement for Implant Stability Tool
    Siemens Healthineers’ DR Systems Cleared by FDA
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Ynvisible Names Michael Robinson CEO, Jani-Mikael Kuusisto SVP Ventures
    IHSMarkit Reports Top Clean-Tech Trends for 2021

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login